Cosmos Health Inc. (COSM): Nasdaq/NYSE listing notice — Cosmos Health receives Nasdaq extension to Nov 3, 2025 for minimum bid price compliance

Cosmos Health Inc.

Nasdaq granted 180-day extension through Nov 3, 2025 to meet $1.00 minimum bid price rule.
Company was previously notified of non-compliance on Nov 6, 2024; initial period ended May 5, 2025.
To regain compliance, closing bid must be at least $1.00 for 10 consecutive business days.
CEO Greg Siokas expressed confidence in meeting listing requirements within extended timeframe.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cosmos Health Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 6, 2025, Cosmos Health Inc. (the “Company”) announced that it has received a formal notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is eligible for an additional one hundred eighty (180) calendar day period, through November 3, 2025, to regain compliance with the Nasdaq’s minimum bid price requirement as one of the continued listing requirements set forth under Nasdaq Listing Rule 5550(a)(2). As previously disclosed, on November 6, 2024, the Company received a non-compliance letter from Nasdaq for its failure to maintain a minimum bid price of $1.00 per share

View on SEC.gov

Browse all listing & compliance notices →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-25-003402

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.